Gallic acid: Molecular rival of cancer

Environmental Toxicology and Pharmacology

Volumn 35, Issue 3, 2013, Pages 473-485

  Verma, Sharad ^a   Singh, Amit ^b   Mishra, Abha ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Cancer; COX; Gallic acid

Indexed keywords

ADAM PROTEIN; ADAM17 PROTEIN; ANTIINFLAMMATORY AGENT; ATM PROTEIN; CASPASE; CYCLOOXYGENASE 2; GALLIC ACID; GALLIC ACID DERIVATIVE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOBUTYLGALLATE 3, 5 DIMETHYLETHER; LINOLEIC ACID; METHYLGALLATE 3, 5 DIMETHYLETHER; NONSTEROID ANTIINFLAMMATORY AGENT; OCTADECA 9,12 DIENYL 3,4,5 HYDROXYBENZOATE; PROTEIN KINASE B; RIBONUCLEOTIDE REDUCTASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CANCER PREVENTION; CARCINOGENESIS; CELL CYCLE; CHEMOPROPHYLAXIS; DIETARY INTAKE; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; GALLIC ACID; HUMANS; NEOPLASMS;

EID: 84875244003     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2013.02.011     Document Type: Article

References (180)

1. Aaltomaa S., Lipponen P., Tammi R., Tammi M., Viitanen J., Kankkunen J.P., Kosma V.M. Strong stromal hyaluronan expression is associated with PSA recurrence in local prostate cancer. Urol. Int. 2002, 69:266-272.
2. Ahn J.Y., Schwarz J.K., Piwnica-Worms H., Canman C.E. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res. 2000, 60:5934-5936.
3. Aicher A., Heeschen C., Mildner-Rihm C., et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med. 2003, 9:1370-1376.
4. Aruoma O.I., Murcia A., Butler J., Haliwell B. Evaluation of the antioxidant and prooxidant actions of gallic acid and its derivatives. J. Agric. Food Chem. 1993, 41:1880-1885.
5. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science 1998, 281:1305-1308.
6. Auvien P., Tammi R., Parkkinen J., Tammi M., Agren U., Johansson R., Hirvikoski P., Eskelinen M., Kosma V.M. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am. J. Pathol. 2000, 156:529-536.
7. Avigdor A., Goichberg P., Shivtiel S., Dar A., Peled A., Samira S., Kollet O., Hershkoviz R., Alon R., Hardan I., Ben-Hur H., Naor D., Nagler A., Lapidot T. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood 2004, 103:2981-2989.
8. Baran C.P., Zeigler M.M., Tridandapani S., Marsh C.B. The role of ROS and RNS in regulating life and death of blood monocytes. Curr. Pharm. Des. 2004, 10:855-866.
9. Bernardi P., Vassanelli S., Veronese P., Colonna C., Szabo I., Zoratti M. Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. J. Biol. Chem. 1992, 267:2934-2939.
10. Bernhaus A., Fritzer-Szekeres M., Grusch M., Saiko P., Krupitza G., Venkateswarlu G., Trimurtulu G., Jaeger W., Szekeres T. Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells. Cancer Lett. 2009, 274:299-304.
11. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997, 385:729-733.
12. Black R.A. Tumor necrosis factor-alpha converting enzyme. Int. J. Biochem. Cell Biol. 2002, 34:1-5.
13. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 1999, 15:269-290.
14. Burma S., Chen B.P., Murphy M., Kurimasa A., Chen D.J. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 2001, 276:42462-42467.
15. Cao L., Kim S., Xiao C., Wang R.H., Coumoul X., Wang X., Li, Xu X.L., Soto J.A.D., Takai H., Mai S., Elledge S.J., Motoyama N., Deng C.X. ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency. EMBO J. 2006, 25:2167-2177.
16. Cao Y., Prescott S.M. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J. Cell. Physiol. 2002, 190:279-286.
17. Capoccia B.J., Shepherd R.M., Link D.C. G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. Blood 2006, 108:2438-2445.
18. Chapla A., Tyagi A., Agarwal R. Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells. Mol. Cancer Ther. 2006, 5:3294-3302.
19. Chen H.M., Wu Y.C., Chia Y.C., Chang F.R., Hsu H.K., Hsieh Y.C., Chen C.C., Yuan S.S. Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate cancer cells. Cancer Lett. 2009, 286:161-171.
20. Chia Y.C., Rajbanshi R., Calhoun C., Chiu R.H. Anti-neoplastic effects of gallic acid, a major component of Toona sinensis leaf extract, on oral squamous carcinoma cells. Molecules 2010, 15:8377-8389.
21. Cory S., Adams J.M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2002, 2:647-656.
22. Creagh E.M., Martin S.J. Caspases: cellular demolition experts. Biochem. Soc. Trans. 2001, 29:696-702.
23. Dar A., Goichberg P., Shinder V., Kalinkovich A., Kollet O., Netzer N., Margalit R., Zsak M., Nagler A., Hardan I., Resnick I., Rot A., Lapidot T. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat. Immunol. 2005, 6:1038-1046.
24. DaSilva S.L., Calgarotto A.K., Chaar J.S., Marangoni S. Isolation and characterization of ellagic acid derivatives isolated from Casearia sylvestris SW aqueous extract with anti-PLA2 activity. Toxicon 2008, 52:655-666.
25. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 1999, 13:2905-2927.
26. Debatin K.M., Krammer P.H. Death receptors in chemotherapy and cancer. Oncogene 2004, 23:2950-2966.
27. Delsignore A., Romeo F., Giaccio M. Content of phenolic substances in basidiomycetes. Mycol. Res. 1997, 101:552-555.
28. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., DuBois R.N. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994, 107:1183-1188.
29. Elford H.L., Freese M., Passamani E., Morris H.P. Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas. J. Biol. Chem. 1970, 245:5228-5233.
30. Eyles A., Davies N.W., Mitsunaga T., Mihara R., Mohammed C. Role of Eucalyptus globulus wound wood extractives: evidence of superoxide dismutase-like activity. Forest Pathol. 2004, 34:225-232.
31. Feingold D.S., Franzen J.S. Pyridine nucleotide linked four-electron transfer dehydrogenases. Trends Plant Sci. 1981, 6:103-105.
32. Fukumura D., Gohongi T., Kadambi A., Izumi Y., Ang J., Yun C., Buerk D.G., Huang P.L., Jain R.K. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:2604-2609.
33. Galati G., O'Brien P.J. Potential toxicity of flavanoids and phenolics: significance for their chemopreventive and anticancer properties. Free Radic. Biol. Med. 2004, 37:287-303.
34. Gerritsen M.E., Carley W.W., Ranges G.E., Shen C.P., Phan S.A., Ligon G.F., Perry C.A. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am. J. Pathol. 1995, 147:278-292.
35. Gichner T. Two types of antimutagenic effects of gallic and tannic acids towards N-nitroso-compounds-induced mutagenicity in the Ames Salmonella assay. Folia Microbiol. 1987, 32:55-62.
36. Golumbic C., Mattill H.A. The antioxidant properties of gallic acid and allied compounds. J. Am. Oil Chem. Soc. 1942, 19:144-145.
37. Gomes C.A., Da Cruz T.G., Andrade J.L., Milhazes N., Borges F., Marques M.P. Anticancer activity of phenolic acids of natural or synthetic origin: a structure-activity study. J. Med. Chem. 2003, 46:5395-5401.
38. Gottlieb R.A. Mitochondria and apoptosis. Biol. Signal Recept. 2001, 10:147-161.
39. Green D.R., Reed J.C. Mitochondria and apoptosis. Science 1998, 281:1309-1312.
40. Gupta R.A., DuBois R.N. Translational studies on Cox-2 inhibitors in the prevention and treatment of colon cancer. Ann. N. Y. Acad. Sci. 2000, 910:196-204.
41. Haliwell B., Aeschbach R., Löliger J., Aruoma O.I. The characterization of antioxidants. Food Chem. Toxicol. 1995, 33:601-617.
42. Harris R.C., Chung E., Coffey R.J. EGF receptor ligands. Exp. Cell Res. 2003, 284:2-13.
43. Heissig B., Hattori K., Dias S., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002, 109:625-637.
44. Hennessy B.T., Smith D.L., Ram P.T., Lu Y., Mills G.B. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov. 2005, 4:988-1004.
45. Hida T., Yatabe Y., Achiwa H., Muramatsu H., Kozaki K., Nakamura S., Ogawa M., Mitsudomi T., Sugiura T., Takahashi T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res. 1998, 58:3761-3764.
46. Ho H., Chang C., Ho W., Liao S., Wu C., Wang C. Anti-metastasis effects of gallic acid on gastric cancer cells involves inhibition of NF-κB activity and downregulation of PI3K/AKT/small GTPase signals. Food Chem. Toxicol. 2010, 48:2508-2516.
47. Ho H., Chang C., Ho W., Liao S., Lin W., Wang C. Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activity. Toxicol. Appl. Pharmacol. 2013, 266:76-85.
48. Horvath Z., Saiko P., Illmer C., Madlener S., Hoechtl T., Bauer W., Erker T., Jaeger W., Fritzer-Szekeres M., Szekeres T. Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells. Exp. Hematol. 2005, 33:329-335.
49. Hseu Y.C., Chen S., Lin W., Hung D., Lin M., Kuo Y., Wang M., Cho H., Wang L., Yang H. Toona sinensis (leaf extracts) inhibit vascular endothelial growth factor (VEGF)-induced angiogenesis in vascular endothelial cells. J. Ethnopharmacol. 2010, 134:111-121.
50. Hsiang C., Hseu Y., Chang Y., Kumar K.J.S., Ho T., Yang H. Toona sinensis and its major bioactive compound gallic acid inhibit LPS-induced inflammation in nuclear factor-jB transgenic mice as evaluated by in vivo bioluminescence imaging. Food Chem. 2013, 136:426-434.
51. Hsu C.L., Huang S.L., Yen G.C. Inhibitory effect of phenolic acids on proliferation of 3T3-L1 preadipocytes in relation to their antioxidant activity. J. Agric. Food Chem. 2006, 54:4191-4197.
52. Hsu C., Lo W., Yen G. Gallic acid induces apoptosis in 3T3-L1 pre-adipocytes via a Fas- and mitochondrial-mediated pathway. J. Agric. Food Chem. 2007, 55:7359-7365.
53. Huh J.W., Lee H.J., Choi M.M., Yang S.J., Yoon S.Y., Kim D.W., Kim S.Y., Choi S.Y., Cho S.W. Identification of a UDP-glucose-binding site of human UDP-glucose dehydrogenase by photoaffinity labeling and cassette mutagenesis. Bioconjug. Chem. 2005, 16:710-716.
54. Huh J.W., Yoon H.Y., Lee H.J., Choi W.B., Yang S.J., Cho S.W. Importance of Gly-13 for the coenzyme binding of human UDP-glucose dehydrogenase. J. Biol. Chem. 2004, 279:37491-37498.
55. Hwanga E.Y., Huha J., Choia M., Choib S.Y., Hongc S., Choa S. Inhibitory effects of gallic acid and quercetin on UDP-glucose dehydrogenase activity. FEBS Lett. 2008, 582:3793-3797.
56. Hynes W.L., Walton S.L. Hyaluronidases of Gram-positive bacteria. FEMS Microbiol. Lett. 2000, 183:201-207.
57. Ichas F., Mazat J.P. From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochem. Biophys. Acta 1998, 1366:33-50.
58. Imai K., Kobayashi M., Wang J., Shinobu N., Yoshida H., Hamada J.C., Shindo M., Higashino F., Tanaka J., Asaka M., Hosokawa M. Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: a possible role in homing of haemopoietic progenitor cells to bone marrow. Br. J. Haematol. 1999, 106:905-911.
59. Inoue M., Sakaguchi N., Isuzugawa K., Tani H., Ogihara Y. Role of reactive oxygen species in gallic acid-induced apoptosis. Biol. Pharm. Bull. 2000, 23:1153-1157.
60. Inoue M., Suzuki R., Sakaguchi N., Li Z., Takeda T., Ogihara Y., Jiang B., Chen Y. Selective induction of cell death in cancer cells by gallic acid. Biol. Pharm. Bull. 1995, 18:1526-1530.
61. Isoyama T., Thwaites D., Selzer M.G., Carey R.I., Barbucci R., Lokeshwar V.B. Differential selectivity of hyaluronidase inhibitors toward acidic and basic hyaluronidases. Glycobiology 2006, 16:11-21.
62. Isuzugawa K., Inoue M., Ogihara Y. Catalase contents in cells determine sensitivity to the apoptosis inducer gallic acid. Biol. Pharm. Bull. 2001, 24:1022-1026.
63. Jo C., Jeong I.Y., Lee N.Y., Kim K.S., Byun M.W. Synthesis of a novel compound from gallic acid and linoleic acid and its biological functions. Food Sci. Biotechnol. 2006, 15:317-320.
64. Justo G.Z., Durán N., Queiroz M.L.S. Natural killer cell activity, lymphocyte proliferation and cytokine profile in tumor-bearing mice treated with MAPA, a magnesium aggregated polymer from Aspergillus oryzae. Immunopharmacol. Immunotoxicol. 2003, 25:305-319.
65. Katakowski M., Chen J., Zhang Z.G., Santra M., Wang Y., Chopp M. Stroke-induced subventricular zone proliferation is promoted by tumor necrosis factor-alpha-converting enzyme protease activity. J. Cereb. Blood Flow Metab. 2007, 27:669-678.
66. Kaur M., Velmurugan B., Rajamanickam S., Agarwal R., Agarwal C. Gallic acid, an active constituent of grape seed extract, exhibits antiproliferative, pro apoptotic and anti-tumorigenic effects against prostate carcinoma xenograft growth in nude mice. Pharm. Res. 2009, 26:2133-2140.
67. Kenny P.A. TACE: a new target in epidermal growth factor receptor dependent tumors. Differentiation 2007, 75:800-808.
68. Kenny P.A. Three-dimensional extracellular matrix culture models of EGFR signaling and drug response. Biochem. Soc. Trans. 2007, 35:665-668.
69. Khanna K.K., Jackson S.P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 2001, 27:247-254.
70. Kheradmand F., Werb Z. Shedding light on sheddases: role in growth an development. Bioessays 2002, 24:8-12.
71. Kiel M.J., Yilmaz O.H., Iwashita T., Yilmaz O.H., Terhorst C., Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005, 121:1109-1121.
72. Kim D.O., Lee K.W., Lee H.J., Lee C.Y. Vitamin C equivalent antioxidant capacity of phenolic phytochemicals. J. Agric. Food Chem. 2002, 50:3713-3717.
73. Kohen R., Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reaction, and methods for their quantification. Toxicol. Pathol. 2002, 30:620-650.
74. Kollet O., Dar A., Shivtiel S., Kalinkovich A., Lapid K., Sztainberg Y., Tesio M., Samstein R.M., Goichberg P., Spiegel A., Elson A., Lapidot T. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat. Med. 2006, 12:657-664.
75. Kollet O., Shivtiel S., Chen Y.Q., Suriawinata J., Thung S.N., Da-beva M.D., Kahn J., Spiegel A., Dar A., Samira S., Goichberg P., Kalinkovich A., Arenzana-Seisdedos F., Nagler A., Hardan I., Revel M., Shafritz D.A., Lapidot T. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34D stem cell recruitment to the liver. J. Clin. Invest. 2003, 112:160-169.
76. Koolwijk P., Peters E., Vecht B.V.D., Hornig C., Weich H.A., Alitalo K., Hicklin D.J., Wu Y., Witte L., Hinsbergh V.W.M.V. Involvement of VEGFR-2 (kdr/flk-1) but not VEGFR-1 (flt-1) in VEGF-A and VEGF-C induced tube formation by human microvascular endothelial cells in fibrin matrices in vitro. Angiogenesis 2001, 4:53-60.
77. Kopp E., Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 1994, 265:956-959.
78. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 1997, 3:614-620.
79. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 2000, 6:513-519.
80. Kroes B.H., van den Berg A.J.J., Quarles van Ufford H.C., van Dijk H., Labadie R.P. Anti-inflammatory activity of gallic acid. Planta Med. 1992, 58:499-504.
81. Kumagai A., Dunphy W.G. The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system. Cell 1991, 64:903-914.
82. Lal A., Glazer C.A., Martinson H.M., Friedman H.S., Archer G.E., Sampson J.H., Riggins G.J. Mutant epidermal growth factor receptor upregulates molecular effectors of tumor invasion. Cancer Res. 2002, 62:3335-3339.
83. Lapointe J., Labrie C. Identification and cloning of a novel androgen-responsive gene, uridine diphosphoglucose dehydrogenase, in human breast cancer cells. Endocrinology 1999, 140:4486-4493.
84. Lee, N.Y., Development of gallic acid-conjugated linoleic acid ester as novel functional materials and its biological activity. Thesis. Chonbuk National University, Korea, p. 48.
85. Li N., Ning-hua T., Zhou J. New chlorine-containing phenoloid from Curculigo capitulata. J. Asian Nat. Prod. Res. 2004, 6:7-10.
86. Liang Y.C., Tsai S., Chen L., Lin-Shiau L., Lin J. Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochem. Pharmacol. 2003, 65:1053-1060.
87. Lin M.T., Lee R.C., Yang P.C., Ho F.M., Kuo M.L. Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 2001, 276:48997-49002.
88. Liu Z., Schwimer J., Liu D., Lewis J., Greenway F.L., York D.A., Woltering E.A. Gallic acid is partially responsible for the antiangiogenic activities of Rubus leaf extract. Phytother. Res. 2006, 20:806-813.
89. Lopez-Girona A., Furnari B., Mondesert O., Russell P. Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature 1999, 397:172-175.
90. Lu X., Lu D., Scully M., Kakkar V. ADAM proteins-therapeutic potential in cancer. Curr. Cancer Drug Targets 2008, 8:720-732.
91. Lu Y., Jiang F., Jiang H., Wu K., Zheng X., Cai Y., Katakowski M., Chopp M., To S.T. Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells. Eur. J. Pharmacol. 2010, 641:102-107.
92. m) in apoptosis; an update. Apoptosis 2003, 8:115-128.
93. Ma J., Luo X.D., Protiva P., Yang H., Ma C., Basile M.J., Weinstein I.B., Kennelly E.J. Bioactive novel polyphenols from the fruit of Manilkara zapota (Sapodilla). J. Nat. Prod. 2003, 7:983-986.
94. Madlener S., Illmer C., Horvath Z., Saiko P., Losert A., Herbacek I., Grusch M., Elford H.L., Krupitza G., Bernhaus A., Fritzer-Szekeres M., Szekeres T. Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells. Cancer Lett. 2007, 245:156-162.
95. Masamoto Y., Ando H., Murata Y., Shimoishi Y., Tada M., Takahata K. Mushroom tyrosinase inhibitory activity of esculetin isolated from seeds of Euphorbia lathyris L. Biosci. Biotechnol. Biochem. 2003, 67:631-634.
96. Matsuoka S., Rotman G., Ogawa A., Shiloh Y., Tamai K., Elledge S.J. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:10389-10394.
97. McGinty A., Chang Y.W.E., Sorokin A., Bokemeyer D., Dunn M.J. Cyclooxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor-differentiated PC12 cells. J. Biol. Chem. 2000, 275:12095-12101.
98. McGowan P.M., McKiernan E., Bolster F., Ryan B.M., Hill A.D., McDermott E.W., Evoy D., O'Higgins N., Crown J., Duffy M.J. ADAM-17 predicts adverse outcome in patients with breast cancer. Ann. Oncol. 2008, 19:1075-1081.
99. Mendelsohn J., Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene 2000, 19:6550-6565.
100. Merry D.E., Korsmeyer S.J. Bcl-2 gene family in the nervous system. Annu. Rev. Neurosci. 1997, 20:245-267.
101. Miller J.S. The biology of natural killer in cancer, infection, and pregnancy. Exp. Hematol. 2001, 29:1157-1168.
102. Mineo J.F., Quintin-Roue I., Lucas B., Buburusan V., Besson G. Glioblastomas: clinical study and search for prognostic factors. Neurochirurgie 2002, 48:500-509.
103. Mirvish S.S., Cardesa A., Wallcave L., Shubik P. Induction of mouse lung adenomas by amines or ureas plus nitrite and by N-nitroso compounds: effect of ascorbate, gallic acid, thiocyanate and caffeine. J. Natl. Cancer Inst. 1975, 55:633-666.
104. Murase T., Kume N., Hase T., Shibuya Y., Nishizawa Y., Tokimitsu I., Kita T. Gallates inhibit cytokine-induced nuclear translocation of NF-κB and expression of leukocyte adhesion molecules in vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1412-1420.
105. Murphy G. The ADAMs: signalling scissors in the tumour microenvironment. Nat. Rev. Cancer 2008, 8:929-941.
106. Murugananthan M., Bhaskar Raju G., Prabhakar S. Removal of tannins and polyhydroxy phenols by electro-chemical techniques. J. Chem. Technol. Biotechnol. 2005, 80:1188-1197.
107. Novotny L., Rauko P., Liska J., Elford H.L., Szekeres T. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice. Cancer Lett. 2006, 233:178-184.
108. Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., Trzaskos J.M., Evans J.F., Taketo M.M. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996, 87:803-809.
109. Ou B.R., Park W.H. Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase. Toxicol. In Vitro 2010, 24:1356-1362.
110. Pablos J.L., Amara A., Bouloc A., Santiago B., Caruz A., Galindo M., Delaunay T., Virelizier J.L., Arenzana-Seisdedos F. Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. Am. J. Pathol. 1999, 155:1577-1586.
111. Padma V.V., Sowmya P., Felix T.A., Baskaran R., Poornima P. Protective effect of gallic acid against lindane induced toxicity in experimental rats. Food Chem. Toxicol. 2011, 49:991-998.
112. Peled A., Grabovsky V., Habler L., Sandbank J., Arenzana-Seisdedos F., Petit I., Hur B., Lapidot T., Alon R. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34 (D) cells on vascular endothelium under shear flow. J. Clin. Invest. 1999, 104:1199-1211.
113. Peng C.Y., Graves P.R., Thoma R.S., Wu Z., Shaw A.S., Piwnica-Worms H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997, 277:1501-1505.
114. Péter A., Dósa G. Detection of phenoloids in some Hungarian inula and Centaurea species. Acta Bot. Hung. 2002, 44:129-135.
115. Petronilli V., Cola C., Massari S., Colonna R., Bernardi P. Physiological effectors modify voltage sensing by the cyclosporine A-sensitive permeability transition pore of mitochondria. J. Biol. Chem. 1993, 268:21939-21945.
116. Polewski K., Kniat S., Slawinska D. Gallic acid, a natural antioxidant, in aqueous and micellar environment: spectroscopic studies. Curr. Top. Biophys. 2002, 26:217-227.
117. Ponomaryov T., Peled A., Petit I., Taichman R.S., Habler L., Sandbank J., Arenzana-Seisdedos F., Magerus A., Caruz A., Fujii C., Nagler A., Lahav M., Szyper-Kravitz M., Zipori D., Lapidot T. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J. Clin. Invest. 2000, 106:1331-1339.
118. Poot M., Teubert H., Rabinovitch P.S., Kavanagh T.J. De novo synthesis of glutathione is required for both entry into and progression through the cell cycle. J. Cell Physiol. 1995, 163:555-560.
119. Rahimi N., Dayanir V., Lashkari K. Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells. J. Biol. Chem. 2000, 275:16986-16992.
120. Ratajczak M.Z., Zuba-Surma E., Kucia M., Reca R., Wojakowski W., Ratajczak J. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 2006, 20:1915-1924.
121. Reca R., Mastellos D., Majka M., Marquez L., Ratajczak J., Franchini S., Glodek S., Honczarenko M., Spruce L.A., Janowska-Wieczorek A., Lambris J.D., Ratajczak M.Z. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood 2003, 101:3784-3793.
122. Reddy T.C., Aparoy P., Babu N.K., Kumar K.A., Kalangi S.K., Reddanna P. Kinetics and docking studies of a COX-2 inhibitor isolated from Terminalia bellerica fruits. Protein Pept. Lett. 2010, 17:1251-1257.
123. Reddy T.C., Reddy D.B., Aparna A., Arunasree K.M., Gupta G., Achari C., Reddy G.V., Lakshmipathi V., Subramanyam A., Reddanna P. Anti-leukemic effect of gallic acid on human leukemia K562 cells: downregulation of COX-2, inhibition of BCR/ABL kinase and NF-κB inactivation. Toxicol. In Vitro 2012, 26:396-405.
124. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
125. Ristimaki A., Honkanen N., Jankala H., Sipponen P., Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res. 1997, 57:1276-1280.
126. Rizzotti M., Cambiaghi D., Gandolfii F., Rindi S., Salvini R., De Luca G. The effect of extracellular matrix modifications on UDP-glucose dehydrogenase activity in cultured human skin fibroblasts. Basic Appl. Histochem. 1986, 30:85-92.
127. Ropponen K., Tammi M., Parkkinen J., Eskelinen M., Tammi R., Lipponen P., Agren U., Alhava E., Kosma V.M. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res. 1998, 58:342-347.
128. Russell P., Nurse P. The mitotic inducer nim1+ functions in a regulatory network of protein kinase homologs controlling the initiation of mitosis. Cell 1987, 49:569-576.
129. Sahin U., Weskamp G., Kelly K., Zhou H.M., Higashiyama S., Peschon J., Hartmann D., Saftig P., Blobel C.P. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 2004, 164:769-779.
130. Sakagami H., Satoh K. Prooxidant action of two antioxidants: ascorbic acid and gallic acid. Anticancer Res. 1997, 17:221-224.
131. Sbaa E., DeWever J., Martinive P., Bouzin C., Frérart F., Balligand J., Dessy C., Feron O. Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis. Circ. Res. 2006, 98:1219-1227.
132. Schnelldorfer T., Gansauge S., Gansauge F., Schlosser S., Beger H.G., Nussler A.K. Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer 2000, 89:1440-1447.
133. Senapathy J.G., Jayanthi S., Viswanathan P., Umadevi P., Nalini N. Effect of gallic acid on xenobiotic metabolizing enzymes in 1,2-dimethyl hydrazine induced colon carcinogenesis in Wistar rats-a chemopreventive approach. Food Chem. Toxicol. 2011, 49:887-892.
134. Sergedieneç E., Jonsson K., Szymusiak H., Tyrakowska B., Rietjens I.M.C.M., Ceçnas N. Prooxidant toxicity of polyphenolic antioxidants to HL-60 cells: description of quantitative structure-activity relationships. FEBS Lett. 1999, 462:392-396.
135. Serrano A., Palacios C., Roy G., Cespon C., Villar M.L., Nocito M., Gonzalez-Porque P. Derivatives of gallic acid induce apoptosis in tumoral cell lines and inhibit lymphocyte proliferation. Arch. Biochem. Biophys. 1998, 350:49-54.
136. Shahrzad S., Bitsch I. Determination of some pharmacologically active phenolic acids in juices by high-performance liquid chromatography. J. Chromatogr. 1996, 16:223-231.
137. Shepherd R.M., Capoccia B.J., Devine S.M., DiPersio J., Trinkaus K.M., Ingram D., Link D.C. Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Blood 2006, 108:3662-3667.
138. Sherr C.J. D-type cyclins. Trends Biochem. Sci. 1995, 20:187-190.
139. Sherr C.J. Cancer cell cycles. Science 1996, 274:1672-1677.
140. Shizukuda Y., Tang S., Yokota R., Ware J.A. Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase C delta activity. Circ. Res. 1999, 85:247-256.
141. Simpson M.A., Wilson C.M., McCarthy J.B. Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice. Am. J. Pathol. 2002, 161:849-857.
142. Singh J., Rai G.K., Upadhyay A.K., Kumar R., Singh K.P. Antioxidant phytochemicals in tomato (Lycopersicon esculentum). Ind. J. Agric. Sci. 2004, 74:3-5.
143. Singh S., Aggarwal B.B. Activation of transcription factor NFkB is suppressed by curcumin (diferulolylmethane). J. Biol. Chem. 1996, 270:24995-25000.
144. Sipkins D.A., Wei X., Wu J.W., Runnels J.M., Côté D., Means T.K., Luster A.D., Scadden D.T., Lin C.P. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 2005, 435:969-973.
145. 2+ signaling and apoptosis. J. Bioenerg. Biomembr. 2000, 32:35-46.
146. Spickenreither M., Braun S., Bernhardt G., Dove S., Buschauer A. Novel 6-O-acylated vitamin C derivatives as hyaluronidase inhibitors with selectivity for bacterial lyases. Bioorg. Med. Chem. Lett. 2006, 16:5313-5316.
147. Sternlicht M.D., Sunnarborg S.W. The ADAM17-amphiregulin-EGFR axis in mammary development and cancer. J. Mammary Gland Biol. Neoplasia 2008, 13:181-194.
148. Strlic M., Radovic T., Kolar J., Pihlar B. Anti- and prooxidative properties of gallic acid in fenton-type systems. J. Agric. Food Chem. 2002, 50:6313-6317.
149. Stumm R.K., Rummel J., Junker V., Culmsee C., Pfeiffer M., Krieglstein J., Hollt V., Schulz S. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J. Neurosci. 2002, 22:5865-5878.
150. Subbaramaiah K., Telang N., Ramonetti J.T., Araki R., DeVito B., Weksler B.B., Dannenberg A.J. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res. 1996, 56:4424-4429.
151. Sumpter L.R., Inayat M.S., Yost E.E., Duvall W., Hagan E., Mayhew C.N., Elford H.L., Gallicchio V.S. In vivo examination of hydroxyurea and the novel ribonucleotide reductase inhibitors trimidox and didox in combination with the reverse transcriptase inhibitor abacavir: suppression of retrovirus-induced immunodeficiency disease. Antiviral Res. 2004, 62:111-120.
152. Takeda E., Weber G. Role of ribonucleotide reductase in expression in the neoplastic program. Life Sci. 1981, 28:1007-1014.
153. Taketo M.M. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J. Natl. Cancer Inst. 1998, 90:1609-1620.
154. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science 1998, 281:1312-1316.
155. Thun M.J., Henley S.J., Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J. Natl. Cancer Inst. 2002, 94:252-266.
156. Tihan T., Elford H.L., Cory J.G. Studies on the mechanisms of inhibition of L1210 cell growth by 3,4-dihydroxybenzohydroxamic acid and 3,4-dihydroxybenzamidoxime. Adv. Enzyme Regul. 1991, 31:71-83.
157. Totzke G., Schulze-Osthoff K., Janicke R.U. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition. Oncogene 2003, 22:8021-8030.
158. Tsatas D., Kanagasundaram V., Kaye A., Novak U. EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines. J. Clin. Neurosci. 2002, 9:282-288.
159. Tucker O.N., Dannenberg A.J., Yang F.K., Zhang F., Teng L.S., Daly J.M., Soslow R.A., Masferrer J.L., Woerner B.M., Koki A.T., Fahey T.J. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res. 1999, 59:987-990.
160. Urbich C., Heeschen C., Aicher A., Sasaki K., Bruhl T., Farhadi M.R., Vajkoczy P. Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat. Med. 2005, 11:206-213.
161. Wacher, V.J., Benet, L.Z., 2001. Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds. US Patent no. 6180666B1.
162. Wells A. EGF receptor. Int. J. Biochem. Cell Biol. 1999, 31:637-643.
163. Wildeboer D., Silvia N., Sang Q.X.A., Bartsch J.W., Pagenstecher A. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness. J. Neuropathol. Exp. Neurol. 2006, 65:516-527.
164. Wojakowski W., Tendera M., Michałowska A., Majka M., Kucia M., Maslankiewicz K., Wyderka R., Ochała A., Ratajczak M.J. Mobilization of CD34/CXCR4D, CD34/CD117D, c-metD stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004, 110:3213-3220.
165. Wysoczynski M., Reca R., Ratajczak J., Kucia M., Shirvaikar N., Honczarenko M., Mills M., Wanzeck J., Janowska-Wieczorek A., Ratajczak M.Z. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood 2005, 105:40-48.
166. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T., Jone D.P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997, 275:1129-1132.
167. Yen G.C., Duh P.D., Tsai H.L. Antioxidant and pro-oxidant properties of ascorbic acid and gallic acid. Food Chem. 2002, 79:307-313.
168. Yoon S.O., Shin S., Lee H.J., Chun H.K., Chung A.S. Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt-dependent matrix metalloproteinase-9 expression. Mol. Cancer Ther. 2006, 5:2666-2675.
169. Yoshioka K., Kataoka T., Hayashi T., Hasegawa M., Ishi Y., Hibasami H. Induction of apoptosis by gallic acid in human stomach cancer KATO III and colon adenocarcinoma COLO205 cell lines. Oncol. Rep. 2000, 6:1221-1223.
170. You B.R., Moon H.J., Han Y.H., Park W.H. Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis. Food Chem. Toxicol. 2010, 48:1334-1340.
171. You B.R., Park W.H. Gallic acid induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase. Toxicol. In Vitro 2010, 24:1356-1362.
172. Zamzami N., Marchetti P., Castedo M., Zanin C., Vayssière J., Petit P.X., Kroemer G. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 1995, 181:1661-1672.
173. Zaneveld L.J., Waller D.P., Anderson R.A., Chany C., Rencher W.F., Feathergill K., Diao X., Doncel G.F., Herold B., Cooper M. Efficacy and safety of a new vaginal contraceptive antimicrobial formulation containing high molecular weight poly(sodium 4-styrenesulfonate). Biol. Reprod. 2002, 66:886-894.
174. Zhao G., Etherton T.D., Martin K.R., Heuvel J.P.V., Gillies P.J., West S.G., Kris-Etherton P.M. Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cell. Biochem. Biophys. Res. Commun. 2005, 336:909-917.
175. Zheng X., Jiang F., Katakowski M., Kalkanis S.N., Hong X., Zhang X., Zhang Z.G., Yang H., Chopp M. Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness. Cancer Sci. 2007, 98:674-684.
176. Zheng X., Jiang F., Katakowski M., Zhang X., Jiang H., Zhang Z.G., Chopp M. Sensitization of cerebral tissue in nude mice with photodynamic therapy induces ADAM17/TACE and promotes glioma cell invasion. Cancer Lett. 2008, 265:177-187.
177. Zhou B.B., Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature 2000, 408:433-439.
178. Zimmermann K.C., Sarbia M., Weber A.A., Borchard F., Gabbert H.E., Schror K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 1999, 59:198-204.
179. Zorov D.B., Juhaszova M., Sollott S.J. Mitochondrial ROS-induced ROS release: an update and review. Biochim. Biophys. Acta 2006, 1757:509-517.
180. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393:595-599.